Literature DB >> 25061053

Distinct chronology of neuronal cell cycle re-entry and tau pathology in the 3xTg-AD mouse model and Alzheimer's disease patients.

Alex C Hradek1, Hyun-Pil Lee1, Sandra L Siedlak1, Sandy L Torres1, Wooyoung Jung1, Ashley H Han1, Hyoung-gon Lee1.   

Abstract

Cell cycle re-entry in Alzheimer's disease (AD) has emerged as an important pathological mechanism in the progression of the disease. This appearance of cell cycle related proteins has been linked to tau pathology in AD, but the causal and temporal relationship between the two is not completely clear. In this study, we found that hyperphosphorylated retinoblastoma protein (ppRb), a key regulator for G1/S transition, is correlated with a late marker for hyperphosphorylation of tau but not with other early markers for tau alteration in the 3xTg-AD mouse model. However, in AD brains, ppRb can colocalize with both early and later markers for tau alterations, and can often be found singly in many degenerating neurons, indicating the distinct development of pathology between the 3xTg-AD mouse model and human AD patients. The conclusions of this study are two-fold. First, our findings clearly demonstrate the pathological link between the aberrant cell cycle re-entry and tau pathology. Second, the chronological pattern of cell cycle re-entry with tau pathology in the 3xTg-AD mouse is different compared to AD patients suggesting the distinct pathogenic mechanism between the animal AD model and human AD patients.

Entities:  

Keywords:  Alzheimer's disease; animal model; cell cycle; retinoblastoma protein (Rb); tau; transgenic mouse

Mesh:

Substances:

Year:  2015        PMID: 25061053      PMCID: PMC5944600          DOI: 10.3233/JAD-141083

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  31 in total

1.  Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau.

Authors:  G A Jicha; R Bowser; I G Kazam; P Davies
Journal:  J Neurosci Res       Date:  1997-04-15       Impact factor: 4.164

Review 2.  Alzheimer's disease and the cell cycle.

Authors:  Arun K Raina; Xiongwei Zhu; Mark A Smith
Journal:  Acta Neurobiol Exp (Wars)       Date:  2004       Impact factor: 1.579

3.  Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.

Authors:  A McShea; P L Harris; K R Webster; A F Wahl; M A Smith
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 4.  'Too much good news' - are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease?

Authors:  Kathleen R Zahs; Karen H Ashe
Journal:  Trends Neurosci       Date:  2010-06-09       Impact factor: 13.837

5.  Identification of Mcm2 phosphorylation sites by S-phase-regulating kinases.

Authors:  Alessia Montagnoli; Barbara Valsasina; Deborah Brotherton; Sonia Troiani; Sonia Rainoldi; Pierluigi Tenca; Antonio Molinari; Corrado Santocanale
Journal:  J Biol Chem       Date:  2006-01-30       Impact factor: 5.157

6.  Altered distribution of cell cycle transcriptional regulators during Alzheimer disease.

Authors:  Kelly L Jordan-Sciutto; Latha M Malaiyandi; Robert Bowser
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

7.  Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Authors:  Robert A Rissman; Wayne W Poon; Mathew Blurton-Jones; Salvatore Oddo; Reidun Torp; Michael P Vitek; Frank M LaFerla; Troy T Rohn; Carl W Cotman
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

8.  Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.

Authors:  David J Bonda; Teresa A Evans; Corrado Santocanale; Jesús Catalá Llosá; Jose Viña; Vladan P Bajic; Rudy J Castellani; Sandra L Siedlak; George Perry; Mark A Smith; Hyoung-gon Lee
Journal:  Aging (Albany NY)       Date:  2009-04       Impact factor: 5.682

9.  BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.

Authors:  Teresa A Evans; Arun K Raina; André Delacourte; Olga Aprelikova; Hyoung-gon Lee; Xiongwei Zhu; George Perry; Mark A Smith
Journal:  Int J Med Sci       Date:  2007-05-12       Impact factor: 3.738

10.  Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice.

Authors:  Michael A Mastrangelo; William J Bowers
Journal:  BMC Neurosci       Date:  2008-08-12       Impact factor: 3.288

View more
  10 in total

1.  Model scenarios for cell cycle re-entry in Alzheimer's disease.

Authors:  Nishtha Pandey; P K Vinod
Journal:  iScience       Date:  2022-06-07

Review 2.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

Review 3.  U1 snRNP Alteration and Neuronal Cell Cycle Reentry in Alzheimer Disease.

Authors:  Bing Bai
Journal:  Front Aging Neurosci       Date:  2018-03-23       Impact factor: 5.750

Review 4.  "Till Death Do Us Part": A Potential Irreversible Link Between Aberrant Cell Cycle Control and Neurodegeneration in the Adult Olfactory Bulb.

Authors:  Saad Omais; Carine Jaafar; Noël Ghanem
Journal:  Front Neurosci       Date:  2018-03-09       Impact factor: 4.677

Review 5.  Senescence as an Amyloid Cascade: The Amyloid Senescence Hypothesis.

Authors:  Chaska C Walton; David Begelman; Wynnie Nguyen; Julie K Andersen
Journal:  Front Cell Neurosci       Date:  2020-05-19       Impact factor: 5.505

6.  Cell cycle activation contributes to isoflurane-induced neurotoxicity in the developing brain and the protective effect of CR8.

Authors:  Bao-Yi Huang; Hong-Bing Huang; Zhi-Jing Zhang; Zhi-Gang Liu; Jun Luo; Min Liu; Tao Luo
Journal:  CNS Neurosci Ther       Date:  2019-01-24       Impact factor: 5.243

7.  CDT2-controlled cell cycle reentry regulates the pathogenesis of Alzheimer's disease.

Authors:  Fang Huang; Minghui Wang; Rong Liu; Jian-Zhi Wang; Eric Schadt; Vahram Haroutunian; Pavel Katsel; Bin Zhang; Xiaochuan Wang
Journal:  Alzheimers Dement       Date:  2018-10-12       Impact factor: 21.566

Review 8.  "Amyloid-beta accumulation cycle" as a prevention and/or therapy target for Alzheimer's disease.

Authors:  Chinthalapally V Rao; Adam S Asch; Daniel J J Carr; Hiroshi Y Yamada
Journal:  Aging Cell       Date:  2020-01-25       Impact factor: 9.304

Review 9.  The Cellular Senescence Stress Response in Post-Mitotic Brain Cells: Cell Survival at the Expense of Tissue Degeneration.

Authors:  Eric Sah; Sudarshan Krishnamurthy; Mohamed Y Ahmidouch; Gregory J Gillispie; Carol Milligan; Miranda E Orr
Journal:  Life (Basel)       Date:  2021-03-11

Review 10.  When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.

Authors:  Santosh R D'Mello
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.